Third Harmonic Reports Ph1 THB335 Results, Gives Strategy Update
11 Feb 2025 //
GLOBENEWSWIRE
Third Harmonic to Attend 7th Annual Evercore HealthCONx Conference
25 Nov 2024 //
GLOBENEWSWIRE
Third Harmonic Bio Announces Q3 2024 Financial Results
07 Nov 2024 //
GLOBENEWSWIRE
Third Harmonic Bio to Attend Investor Conferences in November
07 Nov 2024 //
GLOBENEWSWIRE
Third Harmonic Bio To Attend September Investor Events
10 Sep 2024 //
GLOBENEWSWIRE
Third Harmonic Bio to Participate in Upcoming Investor Conferences
26 Aug 2024 //
GLOBENEWSWIRE
Third Harmonic Bio Announces Q2 2024 Results And Business Update
08 Aug 2024 //
GLOBENEWSWIRE
Third Harmonic Bio to Participate in the Jefferies Global Healthcare Conference
28 May 2024 //
GLOBENEWSWIRE
Third Harmonic Bio Announces Q1 2024 Financials, Business Update
15 May 2024 //
GLOBENEWSWIRE
Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors
28 Mar 2024 //
GLOBENEWSWIRE
Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results
26 Mar 2024 //
GLOBENEWSWIRE
Third Harmonic to Participate in the 44th Annual TD Cowen Health Care Conference
26 Feb 2024 //
GLOBENEWSWIRE
Third Harmonic Appoints Christopher Murphy as Chief Financial & Business Officer
04 Jan 2024 //
GLOBENEWSWIRE
Third Harmonic Bio Announces Third Quarter 2023 Financial Results
09 Nov 2023 //
GLOBENEWSWIRE
Third Harmonic Bio Announces Leadership Changes
31 Oct 2023 //
GLOBENEWSWIRE
Third Harmonic Bio to Participate in the Morgan Stanley GHC
31 Aug 2023 //
GLOBENEWSWIRE
Third Harmonic Bio Announces Second Quarter 2023 Financial Results
10 Aug 2023 //
GLOBENEWSWIRE
Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Candidate THB335
25 Jul 2023 //
GLOBENEWSWIRE
Third Harmonic Bio Announces First Quarter 2023 Financial Results
11 May 2023 //
GLOBENEWSWIRE
Third Harmonic Bio Announces Fourth Quarter and Year-End 2022 Financial Results
29 Mar 2023 //
GLOBENEWSWIRE
Third Harmonic Bio Announces Discontinuation of Phase 1b Study of THB001
15 Dec 2022 //
GLOBENEWSWIRE
Third Harmonic Bio to Participate in Fireside Chat at Conference
21 Nov 2022 //
GLOBENEWSWIRE
Third Harmonic Bio Announces 3Q 2022 Financial Results
09 Nov 2022 //
GLOBENEWSWIRE
Third Harmonic Bio Announces Closing of Upsized Initial Public Offering
19 Sep 2022 //
GLOBENEWSWIRE
Third Harmonic boosts biotech with sector’s top IPO in four months
15 Sep 2022 //
BIOPHARMADIVE
Third Harmonic Bio Announces Pricing of Upsized Initial Public Offering
14 Sep 2022 //
GLOBENEWSWIRE
Third Harmonic braves IPO waters to fund ex-Novartis drug R&D
24 Aug 2022 //
FIERCEBIOTECH
Julie Person Joins Third Harmonic Bio as Chief Administrative Officer
28 Jun 2022 //
GLOBENEWSWIRE
Third Harmonic Bio Appoints Edward R. Conner, M.D., as Chief Medical Officer
06 Jun 2022 //
BUSINESSWIRE
Third Harmonic Bio Strengthens Management Team
06 Apr 2022 //
BUSINESSWIRE
Third Harmonic Bio Appoints Robert Ho as Chief Financial Officer
09 Mar 2022 //
BUSINESSWIRE